Related Experiment Video
Updated: May 30, 2026
11:12
Controlling Parkinson's Disease With Adaptive Deep Brain Stimulation
Published on: July 16, 2014
Palliative care in Parkinson's disease
Nursing Times
|July 26, 2011
Summary
Parkinson's disease is a progressive neurodegenerative disorder requiring complex palliative care. Nurses can effectively support patients by applying palliative care principles across the four disease stages.
Area of Science:
- Neurology
- Palliative Care
- Nursing
Background:
- Parkinson's disease (PD) is a progressive neurodegenerative disorder with no cure.
- PD patients exhibit complex palliative care needs comparable to cancer patients.
- Effective symptom management and supportive care are crucial throughout the disease trajectory.
Purpose of the Study:
- To describe the four distinct stages of Parkinson's disease progression.
- To illustrate how nurses can integrate palliative care principles into each stage of PD care.
- To enhance nursing support for individuals with Parkinson's disease.
Main Methods:
- Literature review on Parkinson's disease stages.
- Analysis of palliative care principles applicable to neurodegenerative conditions.
- Framework development for nursing interventions in PD palliative care.
Main Results:
- Detailed characterization of the four stages of Parkinson's disease.
- Identification of specific palliative care needs at each stage.
- Practical strategies for nurses to implement palliative care interventions.
Conclusions:
- Palliative care is integral to managing Parkinson's disease.
- Nurses play a vital role in providing holistic care at all disease stages.
- Applying palliative care principles can significantly improve the quality of life for PD patients and their families.
Related Concept Videos
01:24Parkinson's Disease: Treatment
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
01:15Parkinson's Disease: Overview
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
01:24Parkinson Disease l: Introduction
Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...
01:24Parkinson Disease ll: Pathophysiology
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
01:25Continuing Care
Continuing care describes the variety of health, personal, and social services provided over a prolonged period. The need for continuing care is increasing because people are living longer. Many people do not have families or others to care for them. Continuing care is mainly for patients who are disabled, functionally dependent, or suffering from a terminal disease. It is available within institutional settings or in homes. Examples include nursing centers or facilities, assisted living,...
01:22Alzheimer's Disease: Treatment
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...